- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MANGOCEUTICALS Aktie jetzt für 0€ handeln | |||||
| 10.07. | MANGOCEUTICALS, INC. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 02.07. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.05. | MANGOCEUTICALS, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 01.04. | MANGOCEUTICALS, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 31.03. | MANGOCEUTICALS, INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 17.03. | Mangoceuticals verklagt Technologie-Dienstleister auf 73 Millionen US-Dollar | 6 | Investing.com Deutsch | ||
| 17.03. | Mangoceuticals, Inc.: Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. | 403 | GlobeNewswire (Europe) | Dallas, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals," the "Company," or "MangoRx"), a company focused on developing, marketing, and selling health... ► Artikel lesen | |
| 17.03. | MANGOCEUTICALS, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 06.03. | Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds | 365 | GlobeNewswire (Europe) | Dallas, TX, March 06, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine... ► Artikel lesen | |
| 23.02. | Mangoceuticals: Aktie steigt nach positiven Daten zu antiviralem Geflügel-Wirkstoff | 2 | Investing.com Deutsch | ||
| 23.02. | Mangoceuticals, Inc.: Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study | 201 | GlobeNewswire (Europe) | Dallas, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine... ► Artikel lesen | |
| 19.02. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.02. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.01. | MANGOCEUTICALS, INC. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 14.11.25 | Mangoceuticals, Inc.: Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs | 2.291 | GlobeNewswire (Europe) | Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") is issuing the following clarification regarding its press release issued earlier... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,423 | -0,70 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| SPINEWAY | 0,140 | +12,70 % | Spineway: First-quarter 2026 revenue | Ecully, April 30, 2026 - 6:00 p.m. First-quarter 2026 revenue High order volumeSlower-than-expected normalization of supply chains2026: growth trajectory confirmed In thousands of euros20262025Change... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| LIFEWARD | 7,250 | 0,00 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,490 | +2,05 % | Imunon, Inc.: IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer | Preliminary data reinforces IMNN-001 immunotherapy's potential for success in the rapidly recruiting Phase 3 OVATION 3 clinical trial Lower rate of minimal residual disease (MRD)Higher ctDNA clearance... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 45,400 | +0,44 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| NUWELLIS, INC | 2,850 | 0,00 % | Nuwellis, Inc.: Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies | MINNEAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that... ► Artikel lesen | |
| INSPIREMD | 0,510 | -2,86 % | InspireMD Inc.: InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures | MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| LOGICMARK | - | - | EQS-News: Benzinga: From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster | EQS-News: Benzinga
/ Key word(s): Healthcare
From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster 19.05.2026 / 15:05... ► Artikel lesen | |
| GT BIOPHARMA | 0,358 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 0,800 | -3,26 % | MYOMO, INC. - 8-K, Current Report | ||
| INOGEN | 5,600 | +0,90 % | Inogen appoints Andy Reding as chief operating officer | ||
| INTELLIGENT BIO SOLUTIONS | 1,790 | -1,10 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market | NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,554 | 0,00 % | Lexaria Bioscience Corp.: Lexaria Updates Business Development | KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many... ► Artikel lesen | |
| GLUCOTRACK | 0,372 | -0,69 % | Glucotrack Gains Slightly on Bridge Financing Deal |
Das Unternehmen MANGOCEUTICALS INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,471 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MANGOCEUTICALS INC finden Sie auf Wallstreet Online.